Replenish Revenue and Competitors
Estimated Revenue & Valuation
- Replenish's estimated annual revenue is currently $1.9M per year.
- Replenish's estimated revenue per employee is $155,000
Employee Data
- Replenish has 12 Employees.
- Replenish grew their employee count by -45% last year.
Replenish's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman | Reveal Email/Phone |
2 | Intellectual Property Consultant | Reveal Email/Phone |
Replenish Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Replenish?
Replenish, Inc. developed the world's smallest implantable, refillable drug pump for the $7 billion retinal therapeutic market (pump currently in clinical investigation, not yet approved by FDA for sale). The MicroPump is implanted under the eye's skin for the purpose of periodically injecting sight-saving medication for patients with age related macular degeneration (AMD). After a 20 minute outpatient surgical procedure, the pump is programmed and recharged wirelessly by the physician and refilled ever 6 months to deliver biotech protein therapies that could only be otherwise administered by a physician's syringe every 4 weeks for life. See our website at www.replenishinc.com for more information.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 12 | 9% | N/A |
#2 | $1.9M | 12 | 0% | N/A |
#3 | $1.8M | 12 | 50% | N/A |
#4 | $1.5M | 12 | 20% | N/A |
#5 | $1M | 12 | -29% | N/A |